RxDoctor Payments Data

Renee Cai, MD

Family Medicine · Brooklyn, NYNPI 1023348364

Payments from drug & device makers

$1,001in general payments, 2019–2025

Across 49 payments — averaging $20.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Esperion Therapeutics, Inc.$440
  • Exact Sciences$204
  • Amarin Pharma, Inc.$90
  • Kowa Pharmaceuticals America, Inc.$78
  • Gilead$68
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$36
  • plus $85 from 4 others

What the payments were for

  • Food & beverage$1,001100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,001 in reported general payments places this provider in the 65th percentile of 4,321 family medicine providers in New York.

See all family medicine providers in New York

Medicare billing

Part B allowed, 2024
$15,548
Medicare patients
16
Services billed
261

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VascepaIcosapent Ethyl518$198,956
Diclofenac Epolamine228$151,376
JardianceEmpagliflozin164$144,931
RybelsusSemaglutide73$90,706
VemlidyTenofovir Alafenamide45$68,141
JanuviaSitagliptin Phosphate67$64,225
EliquisApixaban50$36,670
RestasisCyclosporine55$34,784
Diclofenac Sodium94$32,532
NexletolBempedoic Acid14$11,401
Bepotastine Besilate92$9,682
LinzessLinaclotide14$7,088
BrilintaTicagrelor16$6,693
SymbicortBudesonide/Formoterol Fumarate24$6,410
Halobetasol Propionate74$5,873

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadVemlidy$68$68,14145 claims
AbbVieRestasis, Linzess, Synthroid, Combigan$15$48,276133 claims
PfizerEliquis$13$36,67050 claims
Esperion Therapeutics, Inc.Nexletol$440$11,40114 claims
Kowa Pharmaceuticals America, Inc.Bystolic$78$3,92212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,321 family medicine providers in New York.

Other family medicine in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →